Ubs Asset Management Americas Inc Axonics, Inc. Transaction History

Ubs Asset Management Americas Inc

$381 Billion
Q3 2024

A detailed history of Ubs Asset Management Americas Inc transactions in Axonics, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 125,655 shares of AXNX stock, worth $8.92 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

125,655

Previous 139,231 9.75%

Holding current value

$8.92 Million

Previous $9.36 Million 6.47%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$67.3 - $69.67 $913,664 - $945,839	-13,576 Reduced 9.75%	125,655 $8.75 Million
Q2 2024 Aug 13, 2024	BUY	$66.47 - $69.65 $5.2 Million - $5.45 Million	78,279 Added 128.43%	139,231 $9.36 Million
Q4 2023 Feb 14, 2024	BUY	$49.38 - $63.75 $407,335 - $525,873	8,249 Added 15.65%	60,952 $3.79 Million
Q3 2023 Nov 13, 2023	BUY	$48.64 - $62.51 $289,456 - $371,997	5,951 Added 12.73%	52,703 $2.96 Million
Q1 2023 May 15, 2023	BUY	$52.6 - $67.34 $285,512 - $365,521	5,428 Added 13.14%	46,752 $2.55 Million
Q4 2022 Feb 14, 2023	BUY	$59.56 - $76.6 $38,892 - $50,019	653 Added 1.61%	41,324 $2.58 Million
Q3 2022 Nov 14, 2022	SELL	$57.96 - $78.12 $626,373 - $844,242	-10,807 Reduced 20.99%	40,671 $2.86 Million
Q2 2022 Aug 12, 2022	BUY	$39.5 - $64.42 $82,120 - $133,929	2,079 Added 4.21%	51,478 $2.92 Million
Q1 2022 May 16, 2022	BUY	$43.74 - $62.76 $332,773 - $477,478	7,608 Added 18.2%	49,399 $3.09 Million
Q4 2021 Feb 14, 2022	BUY	$50.01 - $73.35 $265,603 - $389,561	5,311 Added 14.56%	41,791 $2.34 Million
Q3 2021 Nov 15, 2021	BUY	$59.21 - $78.66 $309,609 - $411,313	5,229 Added 16.73%	36,480 $2.37 Million
Q2 2021 Aug 16, 2021	BUY	$51.39 - $66.9 $505,728 - $658,362	9,841 Added 45.96%	31,251 $1.98 Million
Q1 2021 May 14, 2021	BUY	$49.14 - $59.89 $73,710 - $89,835	1,500 Added 7.53%	21,410 $1.28 Million
Q4 2020 Mar 01, 2021	SELL	$42.19 - $51.5 $202,512 - $247,200	-4,800 Reduced 19.43%	19,910 $993,000
Q3 2020 Nov 13, 2020	BUY	$35.33 - $51.04 $209,718 - $302,973	5,936 Added 31.62%	24,710 $1.26 Million
Q2 2020 Aug 14, 2020	BUY	$22.91 - $39.83 $230,795 - $401,247	10,074 Added 115.79%	18,774 $659,000
Q1 2020 May 15, 2020	BUY	$16.44 - $37.73 $143,028 - $328,251	8,700 New	8,700 $221,000

Others Institutions Holding AXNX

# of Institutions

234

Shares Held

42.1M

Call Options Held

83.4K

Put Options Held

65.3K

View Full List

About Axonics, Inc.

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

More about AXNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc Axonics, Inc. Transaction History